加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Nrf2 activation ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain 4 Acta Pharmacologica Sinica 
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-B Pathway 2 International Journal of Endocrinology
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells 5 J Exp Clin Cancer Res
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Porcine Circovirus Type 2 ORF5 Protein Induces Autophagy to Promote Viral Replication via the PERK-eIF2α-ATF4 and mTOR-ERK1/2-AMPK Signaling Pathways in PK-15 Cells 4 Frontiers in Microbiology
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Therapeutic potential of anti-PIK3CG treatment for multiple myeloma via inhibiting c-Myc pathway 4 Heliyon
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Spatiotemporal variations of contact stress between liquid-crystal films and fibroblasts Guide cell fate and skin regeneration 4 Colloids and Surfaces B: Biointerfaces
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation 6 British Journal of Pharmacology
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Inhibition of the Long non-coding RNA ZFAS1 attenuates pathogenic ferroptosis by sponging miR150-5p to activate CCND2 against diabetic cardiomyopathy researchsquare
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer 4 Biochemical pharmacology
A21020 山羊抗兔IgG二抗, HRP辣根过氧化物酶标记 Knockdown of NADPH oxidase 4 reduces mitochondrial oxidative stress and neuronal pyroptosis following intracerebral hemorrhage 6 Neural Regeneration Research
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部